Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome: A Double-Blind Randomized Control Trial.
- 2022-09-22
- RCT · n = 43
- Journal of pediatric gastroenterology and nutrition 76(1)
- Jagadeesh Menon
- Babu Ram Thapa
- Rajni Kumari
- Srikanth Puttaiah Kadyada
- Satyavati Rana
- Sadhna B Lal
- PubMed: 36136861
- DOI: 10.1097/mpg.0000000000003622
- High evidence
- Clinical
There was a significant reduction in median interquartile range (IQR) of total IBS-SSS in psyllium versus placebo [75 (42.5-140) vs 225 (185-270); P < 0.001] at 4 weeks.
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes